APA (7th ed.) Citation

Ota, H., Yasuda, K., Toyota, N., & Masuoka, K. (2026). Clinical Experience with Emicizumab and Rituximab as First-Line Treatment in a Case Series of Acquired Hemophilia A. Hematology Reports, 18(2), 19. https://doi.org/10.3390/hematolrep18020019

Chicago Style (17th ed.) Citation

Ota, Hikari, Kyohei Yasuda, Namie Toyota, and Kazuhiro Masuoka. "Clinical Experience with Emicizumab and Rituximab as First-Line Treatment in a Case Series of Acquired Hemophilia A." Hematology Reports 18, no. 2 (2026): 19. https://doi.org/10.3390/hematolrep18020019.

MLA (9th ed.) Citation

Ota, Hikari, et al. "Clinical Experience with Emicizumab and Rituximab as First-Line Treatment in a Case Series of Acquired Hemophilia A." Hematology Reports, vol. 18, no. 2, 2026, p. 19, https://doi.org/10.3390/hematolrep18020019.